Last reviewed · How we verify

NCT05826496: INHALE

Exercise-induced Effects on Immune Parameters in Healthy Participants

Completed NA Last updated 12 February 2025
What this trial tests

NA trial testing Exercise in Healthy in 59 participants. Completed in 10 February 2025.

Timeline
15 March 2023
Primary endpoint
31 December 2024
10 February 2025

Quick facts

Lead sponsorPer thor Straten
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment59
Start date15 March 2023
Primary completion31 December 2024
Estimated completion10 February 2025
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Per thor Straten

Who can join

Adults 18 to 75, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Exercise has been shown to influence the immune system and, for example, improve anti-viral immune response. However, knowledge of how exercise impacts the immune system is still lacking. Therefore, the goal of this clinical study is to perform a comprehensive multi-parameter analysis of immunological parameters in healthy participants before and after one bout of high-intensity aerobic exercise. The primary endpoint of this study is to determine the exercise-induced changes of anti-viral T cell immunity in peripheral blood against common and recurrent viruses. Up to 70 healthy participants in the age between 18 and 75 will be recruited. The first visit will be for prescreening the health status, answering questionnaires and providing a capillary blood sample for HLA screening. HLA-A2 positive participants will continue on the trial with a VO2 max test for Visit 2 and the supervised aerobic medium- to high-intensity (90% VO2 max) exercise session for Visit 3. Peripheral blood samples will be taken pre-exercise, within 2 minutes post-exercise and 60 minutes post-exercise. These findings may pave the way to define serum markers or cellular immunological traits that provide new insight into how exercise promotes powerful and sustained cellular immune responses.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Exercise Duration Modulates Cortisol Release and Chronic Cortisol Exposure Jeopardises T Cell Effector Functions.
    Luu TV, Fleischer Hach L, Seremet T, Leuchte K, et al · · 2026 · cited 2× · PMID 40796353 · DOI 10.1111/imm.70028
  2. Chemokine Receptor Profile of Circulating Leukocyte Subsets in Response to Acute High-Intensity Interval Training.
    Leuchte K, Fresnillo Saló S, Rahbech A, Byrdal M, et al · · 2026 · PMID 41750333 · DOI 10.3390/biom16020263
  3. Moving for optimal immunity: the effect of acute high-intensity interval training on phenotype, virus specificity and chemokine receptor expression in human CD8+ T cells.
    Leuchte K, Luu TV, Fresnillo Saló S, Madsen K, et al · · 2025 · PMID 41675500 · DOI 10.3389/fimmu.2025.1739657

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05826496.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing